диссертации / 121

111

163. Ristić G.G. Rheumatoid arthritis is an independent risk factor for increased carotid intima-media thickness: impact of anti-inflammatory treatment. /Ristić

G.G., Lepić T., Glisić B., Stanisavljević D., Vojvodić D., Petronijević M.,

Stefanović D.// Rheumatology (Oxford). – 2010. – Vol.49(6). – P.1076-1081.

164.Georgiadis A.N. Early treatment reduces the cardiovascular risk factors in newly diagnosed rheumatoid arthritis patients. /Georgiadis A.N., Voulgari P.V., Argyropoulou M.I., Alamanos Y., Elisaf M., Tselepis A.D., Drosos A.A.// Semin Arthritis Rheum. – 2008. – Vol.38(1). – P.13-19.

165.Koren M.J. Relation of left ventricular mass and geometry to morbidity and mortality in uncomplicated essential hypertension. /Koren M.J., Devereux R.B., Casale P.N., Savage D.D., Laragh J.H.// Ann Intern Med. – 1991. – Vol.114(5). –

P.345-352.

166.Verma A., Meris A. Prognostic implications of left ventricular mass and geometry following myocardial infarction: the VALIANT (VALsartan In Acute myocardial iNfarcTion) Echocardiographic Study. /Verma A., Meris A., Skali H., Ghali J.K., Arnold J.M., Bourgoun M., Velazquez E.J., McMurray J.J., Kober L., Pfeffer M.A., Califf R.M., Solomon S.D.// JACC Cardiovasc Imaging. – 2008.

– Vol.1(5).-P.582-591

167.Pierdomenico S.D. Cardiovascular risk in subjects with left ventricular concentric remodeling at baseline examination: a meta-analysis. /Pierdomenico S.D., Di Nicola M., Pierdomenico A.M., Lapenna D., Cuccurullo F. // J Hum Hypertens. – 2011. – Vol.25(10). – P.585-591

168.di Franco M. Diastolic function abnormalities in rheumatoid arthritis. Evaluation By echo Doppler transmitral flow and pulmonary venous flow: relation with duration of disease. /di Franco M., Paradiso M., Mammarella A.,

Paoletti V., Labbadia G., Coppotelli L., Taccari E., Musca A.// Ann Rheum Dis. –

2000. – Vol.59(3). – P.227-229.

112

169.Abdul Muizz A.M. A cross-sectional study of diastolic dysfunction in rheumatoid arthritis and its association with disease activity. /Abdul Muizz A.M., Mohd Shahrir M.S., Sazliyana S., Oteh M., Shamsul A.S., Hussein H.// Int J Rheum Dis. -2011.- Vol.14(1).-P.18-30.

170.Arslan S. Diastolic function abnormalities in active rheumatoid arthritis evaluation by conventional Doppler and tissue Doppler: relation with duration of disease. /Arslan S., Bozkurt E., Sari R.A., Erol M.K.// Clin Rheumatol. – 2006. –

Vol.25(3). – P.294-299.

171.Yazici D. Echocardiographic evaluation of cardiac diastolic function in patients with rheumatoid arthritis: 5 years of follow-up. /Yazici D., Tokay S., Aydin S., Toprak A., Inanc N., Khan S.R., Fak A.S., Direskeneli H.// Clin Rheumatol. – 2008. – Vol.27(5). – P.647-650.

172.Alpaslan M. Doppler echocardiographic evaluation of ventricular function in patients with rheumatoid arthritis. /Alpaslan M., Onrat E., Evcik D.// Clin Rheumatol. – 2003. – Vol.22(2). – P.84-88.

173.Wislowska M. Diastolic heart function in RA patients. /Wislowska M.,

Jaszczyk B., Kochmański M., Sypuła S., Sztechman M. // Rheumatol Int. – 2008.

–Vol.28(6). – P.513-519.

174.Sil A. Assessment of predictive ability of Epworth scoring in screening of

patients with sleep apnoea. /Sil A., Barr G.J.// Laryngol Otol. – 2012.

– Vol.126(4). – P.372-379.

175.Myasoedova E. Rheumatoid arthritis is associated with left ventricular concentric remodeling: Results of a population-based cross-sectional study. /Myasoedova E., Davis J.M., Crowson C.S., Roger V.L., Karon B.L., Borgeson D.D., Therneau T.M., Matteson E.L., Rodeheffer R.J., Gabriel S.E.// Arthritis Rheum. – 2013. – Apr 1.

113

176.Mirjafari H. Seropositivity is associated with insulin resistance in patients with early inflammatory polyarthritis: results from the Norfolk Arthritis Register (NOAR): an observational study. / Mirjafari H., Farragher T.M., Verstappen S.M., Yates A., Bunn D., Marshall T., Lunt M., Symmons D.P., Bruce I.N. // Arthritis Res Ther. – 2011. – Vol.13(5). – P.159.

177.Smith S.S. Confirmatory factor analysis of the Epworth Sleepiness Scale (ESS) in patients with obstructive sleep apnoea. /Smith S.S., Oei T.P., Douglas J.A., Brown I., Jorgensen G., Andrews J.// Sleep Med. – 2008. – Vol.9(7). – P. 739-744.

178.Reading S.R. Do rheumatoid arthritis patients have a higher risk for sleep apnea? /Reading S.R., Crowson C.S., Rodeheffer R.J., Fitz-Gibbon P.D.,

Maradit-Kremers H., Gabriel S.E.// J Rheumatol. – 2009. – Vol. 36 (9).

–P.1869-1872.

179.Taylor-Gjevre R.M. Components of Sleep Quality and Sleep Fragmentation in Rheumatoid Arthritis and Osteoarthritis. /Taylor-Gjevre R.M., Gjevre J.A., Nair B, Skomro R., Lim H.J.// Musculoskeletal Care. – 2011. – Vol.9(3). –P.152-155.

180.Gjevre J.A. Do sleepy rheumatoid arthritis patients have a sleep disorder? /Gjevre J.A., Taylor-Gjevre R.M., Nair B.V., Lim H.J.// Musculoskeletal Care.

–2012. - Vol.10(4). – P.187-195.

181.Ahbab S. Neck circumference. metabolic syndrome and obstructive sleep apnea syndrome; evaluation of possible linkage. /Ahbab S, Ataoğlu HE, Tuna M,

Karasulu L, Cetin F, Temiz LU, Yenigün M.// Med Sci Monit. – 2013.

- Vol.13(19). – P.111-117.

182.Bruce B. Health Assessment Questionnaire (HAQ) / Bruce B, Fries JF // Clin Exp Rheumatol. – 2005. – Vol.23(5 Suppl 39) – P.14-18.

114

183.Patil S.P. What every clinician should know about polysomnography./ Patil S.P. // Respir Care. – 2010. – Vol.55(9). –P.1179-1195.

184.Punjabi N.M. The epidemiology of adult obstructive sleep apnea. / Punjabi N.M. // Proc Am Thorac Soc. – 2008. – Vol. 15. –P.136-143

185.Ng S.S. Validation of a portable recording device (ApneaLink) for identifying patients with suspected obstructive sleep apnoea syndrome. /Ng S.S., Chan T.O.,

To K.W., Ngai J., Tung A., Ko F.W., Hui D.S.// Intern Med J. – 2009.

– Vol.39(11). – P.757-762.

186.Lang R.M. American Society of Echocardiography's Nomenclature and Standards Committee; Task Force on Chamber Quantification; American College of Cardiology Echocardiography Committee; American Heart Association; European Association of Echocardiography, European Society of Cardiology. Recommendations for chamber quantification. /Lang R.M., Bierig M., Devereux R.B., Flachskampf F.A., Foster E., Pellikka P.A., Picard M.H., Roman M.J., Seward J., Shanewise J., Solomon S., Spencer K.T., St John Sutton M., Stewart W.// Eur J Echocardiogr. – 2006. – Vol.7(2). – P.79-108.

187.de Simone G. Effect of growth on variability of left ventricular mass: assessment of allometric signals in adults and children and their capacity to predict cardiovascular risk. / de Simone G., Devereux R.B., Daniels S.R., Koren M.J., Meyer R.A., Laragh J.H.// J Am Coll Cardiol. – 1995. – Vol.25(5). –

P.1056-1062.

188.Howard G. Carotid artery intimal-medial thickness distribution in general populations as evaluated by B-mode ultrasound. ARIC Investigators. /Howard G., Sharrett A.R., Heiss G, Evans G.W., Chambless L.E., Riley W.A., Burke G.L.// Stroke. – 1993. – Vol.24(9). – P.1297-1304.

189.Mancia G. Guidelines for the management of arterial hypertension: The Task Force for the Management of Arterial Hypertension of the European Society of

115

Hypertension (ESH) and of the European Society of Cardiology (ESC). /Mancia

G., De Backer G., Dominiczak A., Cifkova R. et. al.// Eur Heart J. – 2007.

–Vol.28(12). – P.1462-1536.

190.Chen H. Evaluation of a portable recording device (ApneaLink) for case selection of obstructive sleep apnea. /Chen H., Lowe A.A., Bai Y., Hamilton P., Fleetham J.A., Almeida F.R.// Sleep Breath. – 2009. – Vol.13(3). – P.213-219.

191.Myasoedova E. Epidemiology of rheumatoid arthritis: rheumatoid arthritis and mortality. /Myasoedova E., Davis J.M., Crowson C.S., Gabriel S.E. // Current Rheumatology Reports. – 2010. – Vol.12(5). – P.379-385.

192.Ganau A. Patterns of left ventricular hypertrophy and geometric remodeling in essential hypertension. /Ganau A., Devereux R.B., Roman M.J., de Simone G., Pickering T.G., Saba P.S., Vargiu P., Simongini I., Laragh J.H. // J Am Coll Cardiol. – 1992. – Vol.19(7). – P. 1550-1558.

193.Goodson N.J. Traditional cardiovascular risk factors measured prior to the onset of inflammatory polyarthritis. /Goodson N.J., Silman A.J., Pattison D.J., Lunt M., Bunn D., Luben R., Day N., Khaw K.T., Symmons D.P.// Rheumatology (Oxford). – 2004. – Vol. 43(6). – P.731-736.

194.Chung C.P. Increased coronary-artery atherosclerosis in rheumatoid arthritis: relationship to disease duration and cardiovascular risk factors. /Chung C.P., Oeser A., Raggi P., Gebretsadik T., Shintani A.K., Sokka T., Pincus T., Avalos I., Stein C.M. // Arthritis Rheum. – 2005. – Vol.52(10). – P.3045-3053.

195.Dessein P.H. Independent role of conventional cardiovascular risk factors as predictors of C-reactive protein concentrations in rheumatoid arthritis. /Dessein P.H., Norton G.R., Woodiwiss A.J., Joffe B.I., Solomon A.// Rheumatol. – 2007.

–Vol.34(4). – P.681-688.

116

196.Brady S.R. The role of traditional cardiovascular risk factors among patients with rheumatoid arthritis. / Brady S.R., de Courten B., Reid C.M., Cicuttini F.M., de Courten M.P., Liew D. // J Rheumatol. – 2009. – Vol.36(1). – P. 34-40.

197.Panoulas V.F. Prevalence and associations of hypertension and its control in patients with rheumatoid arthritis. /Panoulas V.F., Douglas K.M., Milionis H.J., Stavropoulos-Kalinglou A., Nightingale P., Kita M.D., Tselios A.L., Metsios G.S., Elisaf M.S., Kitas G.D.// Rheumatology. – 2007. – Vol.46. –P.1477-1482.

198.Gabriel S.E. Why do people with rheumatoid arthritis still die prematurely? Ann Rheum Dis. – 2008. – Vol.67. – P. 30-34.

199.Рекомендации экспертов ВНОК по диагностике и лечению метаболического синдрома, второй пересмотр, 2009.

200.Wolk R. Sleep and the metabolic syndrome. / Wolk R., Somers V.K.// Exp Physiol. – 2007. – Vol.92(1). – P.67-78.

201.Calvin A.D. Obstructive sleep apnea, inflammation, and the metabolic syndrome. /Calvin A.D., Albuquerque F.N., Lopez-Jimenez F., Somers V.K.// Metab Syndr Relat Disord. – 2009. – Vol. 7(4). – P.271-278.

202.Corrales A. Carotid ultrasound is useful for the cardiovascular risk

stratification of patients with rheumatoid arthritis: results of a population-based study. /Corrales A., González-Juanatey C., Peiró M.E., Blanco R., Llorca J.,

González-Gay M.A.// Ann Rheum Dis. – 2014. – Vol. 73(4). – P. 722-727.

203.Veselinovic M.V. Carotid artery intima-media thickness and brachial artery flow-mediated vasodilatation in patients with rheumatoid arthritis. /Veselinovic M.V., Zivkovic V.I., Toncev S., Tasic N., Bogdanovic V., Djuric D.M., Jakovljevic V.L.J.// Vasa. – 2012. – Vol.41(5). – P.343-351.

204.Paramsothy P. Association of combinations of lipid parameters with carotid intima-media thickness and coronary artery calcium in the MESA (Multi-Ethnic

117

Study of Atherosclerosis). /Paramsothy P., Knopp R.H., Bertoni A.G., Blumenthal R.S., Wasserman B.A., Tsai M.Y., Rue T., Wong N.D., Heckbert S.R. // J Am Coll Cardiol. – 2010. – Vol.6(13). – P.1034-1041.

205.Skare T.L. Carotid intima-media thickness in spondyloarthritis patients. /Skare T.L., Verceze G.C., Oliveira A.A., Perreto S. // Sao Paulo Med J. – 2013. – Vol. 131(2). – P.100-105.

206.Ребров А.П. Факторы риска сердечно-сосудистой патологии у больных ревматоидным артритом. /Ребров А.П., Никитина Н.М.// Клиническая медицина. – 2008. – №2. – C.56-59.

207.Micha R. Systematic review and meta-analysis of methotrexate use and risk of cardiovascular disease. /Micha R., Imamura F., Wyler von Ballmoos. M,

Solomon D.H., Hernán M.A., Ridker P.M., Mozaffarian D.// Am J Cardiol.

–2011. – Vol. 108(9). – P.1362-1370.

208.Everett B.M. Rationale and design of the Cardiovascular Inflammation Reduction Trial: a test of the inflammatory hypothesis of atherothrombosis. /Everett B.M., Pradhan A.D., Solomon D.H., Paynter N., Macfadyen J., Zaharris E., Gupta M., Clearfield M., Libby P., Hasan A.A., Glynn R.J., Ridker P.M.// Am Heart J. – 2013. – Vol.166(2). – P.199-207.

209.Gonzalez-Juanatey C. Echocardiographic and Doppler findings in long-term treated rheumatoid arthritis patients without clinically evident cardiovascular disease. /Gonzalez-Juanatey C., Testa A., Garcia-Castelo A., Garcia-Porrua C., Llorca J., Ollier W.E., Gonzalez-Gay M.A.// Semin Arthritis Rheum. – 2004.

–Vol.33(4). – P.231-238.

210.Baessler A. Treatment for sleep apnea by continuous positive airway pressure improves levels of inflammatory markers - a meta-analysis. /Baessler A., Nadeem R., Harvey M., Madbouly E., Younus A., Sajid H., Naseem J., Asif A., Bawaadam H.J. // Inflamm (Lond). – 2013. – Vol.10(1). – P.13.

118

211.Popovic R.M. Upper airway muscle activity in normal women: influence of hormonal status. /Popovic R.M., White D.P.// J Appl Physiol. – 1998. – Vol. 84(3). – P.1055-1062.

212.Manber R. The effects of hormone replacement therapy on sleep-disordered breathing in postmenopausal women: a pilot study. /Manber R., Kuo T.F., Cataldo N., Colrain I.M. // Sleep. – 2003. – Vol. 26(2). – P.163-168.

213.Wesström J. Sleep apnea and hormone replacement therapy: a pilot study and a literature review./ Wesström J., Ulfberg J., Nilsson S. // Acta Obstet Gynecol Scand. – 2005. – Vol. 84(1). – P. 54-57.

214.Carter R. Obesity and obstructive sleep apnea: or is it OSA and obesity? /Carter R., Watenpaugh D.E. // Pathophysiology. – 2008. – Vol. 15(2). – P. 7177.

215.Pillar G. Abdominal fat and sleep apnea: the chicken or the egg? /Pillar G., Shehadeh N.// Diabetes Care. – 2008. – Vol.31. – P.303-309.

216.Kritikou I. Sleep Apnea, Sleepiness, Inflammation and Insulin Resistance in middle-aged Men and Women. /Kritikou I., Basta M., Vgontzas A.N., Pejovic S., Liao D., Tsaoussoglou M., Bixler E., Stefanakis Z., Chrousos G.// Eur Respir J.

– 2014. – Vol. 43 (1). – P.145-155.

217.Trenell M.I. Influence of constant positive airway pressure therapy on lipid storage, muscle metabolism and insulin action in obese patients with severe obstructive sleep apnoea syndrome. /Trenell M.I., Ward J.A., Yee B.J., Phillips

C.L., Kemp G.J., Grunstein R.R, Thompson C.H. // Diabetes Obes Metab.

– 2007. – Vol. 9(5). –P.679-687.

218.Kawaguchi Y. Different impacts of neck circumference and visceral obesity on the severity of obstructive sleep apnea syndrome. /Kawaguchi Y., Fukumoto S.,

119

Inaba M., Koyama H., Shoji T., Shoji S., Nishizawa Y.// Obesity (Silver Spring).

–2011. – Vol. 19(2). – P. 276-282.

219.Usui Y. Coexistence of obstructive sleep apnoea and metabolic syndrome is independently associated with left ventricular hypertrophy and diastolic dysfunction. /Usui Y., Takata Y., Inoue Y., Shimada K., Tomiyama H., Nishihata Y., Kato K., Shiina K., Yamashina A.// Sleep Breath. – 2012. – Vol. 16(3).

–P.677-684.

220.Cioffi G. Analysis of left ventricular systolic function by midwall mechanics in patients with obstructive sleep apnoea. /Cioffi G., Russo T.E., Selmi A., Stefenelli C., Furlanello F.// Eur J Echocardiogr. – 2011. – Vol.12(1). – P.61-68.

221.Baguet J.P. Early cardiovascular abnormalities in newly diagnosed obstructive sleep apnea. /Baguet J.P., Nadra M., Barone-Rochette G., Ormezzano O., Pierre H., Pépin J.L.//Vasc Health Risk Manag. – 2009. – Vol.5. – Р.10631073.

222.Cloward T.V. Left ventricular hypertrophy is a common echocardiographic abnormality in severe obstructive sleep apnea and reverses with nasal continuous positive airway pressure. / Cloward T.V.,Walker J.M., Farney R.J., Anderson J.L.// Chest.- 2003. – Vol. 124(2). – Р.594-601.